These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17639045)

  • 1. Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells.
    Choi HK; Yang JW; Roh SH; Han CY; Kang KW
    Endocr Relat Cancer; 2007 Jun; 14(2):293-303. PubMed ID: 17639045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
    Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
    Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
    Vendrell JA; Bieche I; Desmetz C; Badia E; Tozlu S; Nguyen C; Nicolas JC; Lidereau R; Cohen PA
    Endocr Relat Cancer; 2005 Mar; 12(1):75-92. PubMed ID: 15788640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
    Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
    Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1-mediated FoxO1 deacetylation is essential for multidrug resistance-associated protein 2 expression in tamoxifen-resistant breast cancer cells.
    Choi HK; Cho KB; Phuong NT; Han CY; Han HK; Hien TT; Choi HS; Kang KW
    Mol Pharm; 2013 Jul; 10(7):2517-27. PubMed ID: 23763570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase induction in tamoxifen-resistant breast cancer: Role of phosphoinositide 3-kinase-dependent CREB activation.
    Phuong NT; Lim SC; Kim YM; Kang KW
    Cancer Lett; 2014 Aug; 351(1):91-9. PubMed ID: 24836190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells.
    Zhao W; Zhang Q; Kang X; Jin S; Lou C
    Biochem Biophys Res Commun; 2009 Mar; 380(3):699-704. PubMed ID: 19285025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
    Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
    Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
    Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer.
    Chan CM; Lykkesfeldt AE; Parker MG; Dowsett M
    Clin Cancer Res; 1999 Nov; 5(11):3460-7. PubMed ID: 10589759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression.
    Way TD; Lee HH; Kao MC; Lin JK
    Eur J Cancer; 2004 Sep; 40(14):2165-74. PubMed ID: 15341993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells.
    Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA
    Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased production of vascular endothelial growth factor in adriamycin-resistant breast cancer cells.
    Kim JA; Cho KB; Kim MR; Park BC; Kim SK; Lee MY; Kang KW
    Cancer Lett; 2008 Sep; 268(2):225-32. PubMed ID: 18471962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
    Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of PKCalpha is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model.
    Lin X; Yu Y; Zhao H; Zhang Y; Manela J; Tonetti DA
    Carcinogenesis; 2006 Aug; 27(8):1538-46. PubMed ID: 16513679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen.
    Maraqa L; Cummings M; Peter MB; Shaaban AM; Horgan K; Hanby AM; Speirs V
    Clin Cancer Res; 2008 Jan; 14(2):405-11. PubMed ID: 18223215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
    Conze D; Weiss L; Regen PS; Bhushan A; Weaver D; Johnson P; Rincón M
    Cancer Res; 2001 Dec; 61(24):8851-8. PubMed ID: 11751408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.